Continuum Advisory, LLC Pfizer Inc Transaction History

Continuum Advisory, LLC

$680 Million
Q2 2024

A detailed history of Continuum Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Continuum Advisory, LLC holds 25,185 shares of PFE stock, worth $672,943. This represents 0.1% of its overall portfolio holdings.

Number of Shares

25,185

Previous 24,825 1.45%

Holding current value

$672,943

Previous $688,000 2.33%

% of portfolio

0.1%

Previous 0.1%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$25.26 - $29.6 $9,093 - $10,656	360 Added 1.45%	25,185 $704,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $357,722 - $410,779	-13,817 Reduced 35.76%	24,825 $688,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $761,193 - $988,706	-29,131 Reduced 42.98%	38,642 $1.11 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $184,549 - $215,720	5,751 Added 9.27%	67,773 $2.25 Million
Q2 2023 Dec 13, 2023	SELL	$36.12 - $41.79 $687,471 - $795,389	-19,033 Reduced 23.48%	62,022 $2.27 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $687,471 - $795,389	-19,033 Reduced 23.48%	62,022 $2.27 Million
Q1 2023 Dec 13, 2023	BUY	$39.39 - $51.28 $281,914 - $367,010	7,157 Added 9.68%	81,055 $3.31 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $281,914 - $367,010	7,157 Added 9.68%	81,055 $3.31 Million
Q4 2022 Dec 13, 2023	BUY	$41.75 - $54.5 $17,284 - $22,563	414 Added 0.56%	73,898 $3.79 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $17,284 - $22,563	414 Added 0.56%	73,898 $3.79 Million
Q3 2022 Dec 13, 2023	BUY	$43.76 - $53.42 $463,768 - $566,145	10,598 Added 16.85%	73,484 $3.22 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $463,768 - $566,145	10,598 Added 16.85%	73,484 $2.06 Million
Q2 2022 Dec 13, 2023	BUY	$46.53 - $55.17 $175,604 - $208,211	3,774 Added 6.38%	62,886 $3.3 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $175,604 - $208,211	3,774 Added 6.38%	62,886 $1.91 Million
Q1 2022 Dec 13, 2023	BUY	$45.75 - $56.69 $844,590 - $1.05 Million	18,461 Added 45.41%	59,112 $3.06 Million
Q1 2022 May 17, 2022	BUY	$45.75 - $56.69 $844,590 - $1.05 Million	18,461 Added 45.41%	59,112 $1.6 Million
Q4 2021 Dec 13, 2023	BUY	$41.32 - $61.25 $64,500 - $95,611	1,561 Added 3.99%	40,651 $2.4 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $64,500 - $95,611	1,561 Added 3.99%	40,651 $833,000
Q3 2021 Dec 13, 2023	BUY	$39.25 - $50.42 $1.07 Million - $1.38 Million	27,351 Added 232.99%	39,090 $1.68 Million
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $1.07 Million - $1.38 Million	27,351 Added 232.99%	39,090 $547,000
Q2 2021 Dec 13, 2023	SELL	$35.91 - $40.68 $2.01 Million - $2.28 Million	-56,034 Reduced 82.68%	11,739 $459,000
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $146,620 - $166,096	4,083 Added 53.33%	11,739 $460,000
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $39,417 - $44,455	1,177 Added 18.17%	7,656 $288,000
Q4 2020 May 17, 2021	BUY	$33.47 - $42.56 $216,852 - $275,746	6,479 New	6,479 $238,000
Q2 2020 May 18, 2021	SELL	$30.12 - $36.54 $217,737 - $264,147	-7,229 Closed	0 $0
Q1 2020 May 18, 2021	BUY	$27.03 - $38.62 $195,399 - $279,183	7,229 New	7,229 $230,000
Q1 2019 May 18, 2021	SELL	$37.5 - $41.2 $183,975 - $202,127	-4,906 Closed	0 $0
Q4 2018 May 18, 2021	SELL	$38.47 - $43.86 $118,987 - $135,658	-3,093 Reduced 38.67%	4,906 $214,000
Q3 2018 May 18, 2021	SELL	$34.47 - $41.81 $6,514 - $7,902	-189 Reduced 2.31%	7,999 $354,000
Q2 2018 May 18, 2021	SELL	$32.98 - $35.16 $75,326 - $80,305	-2,284 Reduced 21.81%	8,188 $297,000
Q1 2018 May 18, 2021	SELL	$31.91 - $37.02 $253,014 - $293,531	-7,929 Reduced 43.09%	10,472 $372,000
Q4 2017 May 18, 2021	BUY	$33.26 - $35.29 $215,990 - $229,173	6,494 Added 54.54%	18,401 $666,000
Q3 2017 May 18, 2021	SELL	$31.0 - $34.15 $15,407 - $16,972	-497 Reduced 4.01%	11,907 $425,000
Q2 2017 May 18, 2021	BUY	N/A	1,036 Added 9.11%	12,404 $417,000
Q1 2017 May 18, 2021	BUY	N/A	11,368	11,368 $389,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Pfizer Inc Transaction History